Fracture Multiple, Fractures, Bone
Conditions
Brief summary
The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).
Detailed description
The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU). Safety will be established by recording the incidence and frequency of complications and adverse events. Relationship of the events to either implant or instrumentation should be specified. Performance and clinical benefits will be assessed by analyzing fracture healing/fusion and the overall pain and functional performance of subjects who received the Biomet Cannulated Bone Screws by recording survey questions. Zimmer Biomet defines the expected performance rate for Cannulated Screws for long and small bone fractures to be a union rate of at least 81% at 8-12 months.
Interventions
DEVICEBiomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.
Sponsors
Zimmer Biomet
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient must be 18 years of age or older. All patients operated on for the following indications: * Group 1, Small Cannulated Screws (4.0mm and smaller diameter) are intended for use in: 1. Fixation of small bones, including those in the foot, patella, ankle, wrist and elbow. 2. Arthrodesis of the foot, wrist and elbow. 3. Small and long bone osteotomies. 4. Fracture fixation of small bones, small bone fragments and long bones. * Group 2, Large Cannulated Screws (5mm and larger in diameter) are intended for use in: 1. Fixation of fractures in long bones and long bone fragments. 2. Long bone osteotomies (femur, tibia, foot, ankle, olecranon). 3. Arthrodesis and fracture fixation of the foot and ankle, such as Jones fractures of the fifth metatarsal, and Calcaneal fractures. * Group 3, Large Cannulated Screws (6.5mm and larger in diameter) are intended for use in: 1. Slipped capital femoral epiphysis 2. Pediatric femoral neck fractures 3. Tibial plateau fractures 4. SI joint disruptions 5. Intercondylar femur fractures 6. Subtalar arthrodesis 7. Fixation of pelvis and iliosacral joint * Patients must have the ability and willingness to follow instructions, including control of weight and activity levels. * Patient must have a good nutritional state.
Exclusion criteria
* Infections. * Patient conditions including blood supply limitations, insufficient quantity or quality of bone. * Patients with mental or neurologic conditions who are unwilling or incapable fo following postoperative care instructions. * Foreign body sensitivity where material sensitivity is suspected or unknown, testing is to be completed prior to implantation of the device. * Patient is a prisoner. * Patient is a current alcohol or drug abuser. * Patient is known to be pregnant or breastfeeding. * Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Device Safety Assessed Through the Incidence and Frequency of Revisions, Complications, and Adverse Events | Out to12+ months | Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Device Performance and Clinical Benefits Assessed by a Patient Questionnaire Case Report Form | Out to 12+ months | Performance and clinical benefits demonstrated by the assessment of survey questions. |
| Device Performance and Clinical Benefits Assessed by a Follow-Up Analysis Case Report Form | Out to 12+ months | Performance and clinical benefits demonstrated by the assessment of fracture healing/fusion and survey questions. |
Countries
United States
Contacts
STUDY_DIRECTORHillary Overholser
Zimmer Biomet
Outcome results
None listed